Christeen Moburg
Company: Sangamo Therapeutics
Job title: Director Patient Advocacy
Seminars:
Development of Leriglitazone in Rare Neurodegenerative Diseases 1:50 pm
day: Day Two
Patient Engagement Throughout the Drug Development Process in Genomic Medicines 1:20 pm
• Emphasizing the importance of early engagement for clinical trial recruitment • How to design a compelling engagement process in order to maximize patient trial retention • A case study of patient engagement for rare metabolic disease clinical trialsRead more
day: Day Two
Panel Discussion: Tackling Ultra-Rare Inborn Errors of Metabolism: Addressing a Huge Unmet Medical Need 3:40 pm
This panel discussion will set to map out the future for ultra-rare inherited metabolic therapeutics. Analyze current and future treatment options and explore how a patient-centric approach to drug development can be utilized through collaborations with advocacy groups. This panel will also address the role of industry-academia collaborations to access and augment novel therapeutic innovations…Read more
day: Day One